• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

智能通行将防止皮下植入式心律转复除颤器(S-ICD)的不当操作。

SMART pass will prevent inappropriate operation of S-ICD.

作者信息

Tachibana Motomi, Nishii Nobuhiro, Banba Kimikazu, Fujita Shinpei, Ikeda Etsuko, Okawa Keisuke, Morita Hiroshi, Ito Hiroshi

机构信息

Department of Cardiology Sakakibara Heart Institute of Okayama Okayama Japan.

Department of Cardiovascular Therapeutics Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.

出版信息

J Arrhythm. 2018 Nov 20;35(1):86-91. doi: 10.1002/joa3.12141. eCollection 2019 Feb.

DOI:10.1002/joa3.12141
PMID:30805048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6373830/
Abstract

BACKGROUND

Compared to screening ECG before implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), selectable vectors without T-wave oversensing increase after S-ICD implantation. Newer algorithms have recently become available to reduce T-wave oversensing, such as SMART pass (SP). With this function, more selectable vectors are identified after S-ICD implantation. However, this improvement in eligibility utilizing SP has not yet been well validated. We aimed to clarify S-ICD eligibility before and after S-ICD implantation with and without SP.

METHODS

Participants comprised 34 patients implanted with an S-ICD at Okayama University Hospital and its affiliated hospitals between February 2016 and August 2017. A total of 102 S-ICD vectors were assessed for eligibility before and after S-ICD implantation, at rest and during exercise testing. Vector availability was evaluated in the presence and absence of SP after S-ICD implantation.

RESULTS

Subcutaneous implantable cardioverter-defibrillator eligibility was significantly better after implantation even without SP than S-ICD screening before S-ICD implantation, both at rest (before 65.7% vs after 95.1%, < 0.01) and during exercise (before 59.3% vs after 90.6%, < 0.01). SP improved S-ICD eligibility during exercise (SP on 97.9% vs off 90.6%, = 0.03). Multivariate analysis showed the prevalence of S-ICD eligibility increased significantly after S-ICD implantation compared to screening before implantation. SP further increased selectable vectors in multivariate analysis.

CONCLUSION

Available vectors increased significantly after S-ICD implantation compared to preoperative vectors as assessed by S-ICD screening ECG. T-wave oversensing during exercise has been an unresolved issue for S-ICD, but SP will help prevent inappropriate operation with S-ICD.

摘要

背景

与皮下植入式心脏复律除颤器(S-ICD)植入前的筛查心电图相比,S-ICD植入后无T波过度感知的可选向量增加。最近出现了更新的算法来减少T波过度感知,如SMART pass(SP)。有了这个功能,S-ICD植入后可识别更多的可选向量。然而,利用SP在合格性方面的这种改善尚未得到充分验证。我们旨在阐明在有和没有SP的情况下,S-ICD植入前后的S-ICD合格性。

方法

研究对象包括2016年2月至2017年8月期间在冈山大学医院及其附属医院植入S-ICD的34例患者。在S-ICD植入前后、静息时和运动试验期间,共评估了102个S-ICD向量的合格性。在S-ICD植入后,在有和没有SP的情况下评估向量可用性。

结果

即使没有SP,皮下植入式心脏复律除颤器的合格性在植入后也显著优于S-ICD植入前的S-ICD筛查,无论是在静息时(植入前为65.7%,植入后为95.1%,<0.01)还是在运动期间(植入前为59.3%,植入后为90.6%,<0.01)。SP改善了运动期间的S-ICD合格性(开启SP时为97.9%,关闭时为90.6%,P = 0.03)。多变量分析显示,与植入前的筛查相比,S-ICD植入后S-ICD合格性的患病率显著增加。在多变量分析中,SP进一步增加了可选向量。

结论

与通过S-ICD筛查心电图评估的术前向量相比,S-ICD植入后可用向量显著增加。运动期间的T波过度感知一直是S-ICD尚未解决的问题,但SP将有助于防止S-ICD的不适当操作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea7/6373830/ed6feb754ca0/JOA3-35-86-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea7/6373830/ed6feb754ca0/JOA3-35-86-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea7/6373830/ed6feb754ca0/JOA3-35-86-g001.jpg

相似文献

1
SMART pass will prevent inappropriate operation of S-ICD.智能通行将防止皮下植入式心律转复除颤器(S-ICD)的不当操作。
J Arrhythm. 2018 Nov 20;35(1):86-91. doi: 10.1002/joa3.12141. eCollection 2019 Feb.
2
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.SMART Pass 滤器对阿义马林诱导 Brugada 综合征和皮下植入式心脏复律除颤器植入失败患者的影响:前瞻性多中心研究结果。
Europace. 2022 May 3;24(5):845-854. doi: 10.1093/europace/euab230.
3
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.因T波过度感知导致的不适当皮下植入式心律转复除颤器电击可被预防:对管理的启示
Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.
4
Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.皮下植入式心脏复律除颤器治疗 Brugada 综合征患者的有效性。
Heart Vessels. 2021 Feb;36(2):260-266. doi: 10.1007/s00380-020-01683-0. Epub 2020 Aug 24.
5
Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.运动负荷试验显示,布加综合征患者不适合植入皮下植入式心律转复除颤器。
J Cardiovasc Electrophysiol. 2017 Dec;28(12):1454-1459. doi: 10.1111/jce.13315. Epub 2017 Sep 1.
6
SMART Pass automatic deactivation of subcutaneous implantable cardioverter-defibrillators.
Heart Rhythm. 2025 May;22(5):1255-1263. doi: 10.1016/j.hrthm.2024.08.037. Epub 2024 Aug 23.
7
Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.使用心电图筛查工具来确定皮下植入式心律转复除颤器的适用对象。
Heart Rhythm. 2014 Aug;11(8):1361-6. doi: 10.1016/j.hrthm.2014.04.025. Epub 2014 Apr 19.
8
Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.前瞻性盲法评估一种新型感测方法,旨在减少皮下植入式心律转复除颤器的不适当电击。
Heart Rhythm. 2018 Oct;15(10):1515-1522. doi: 10.1016/j.hrthm.2018.05.011. Epub 2018 Jun 8.
9
Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator.运动心电图在植入皮下植入式心脏除颤器后筛查 T 波过感知中的作用。
Heart Rhythm. 2017 Oct;14(10):1436-1439. doi: 10.1016/j.hrthm.2017.06.022. Epub 2017 Jun 15.
10
Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators.心电图变化对皮下植入式心脏除颤器感知过度的临床影响。
Heart Rhythm. 2022 Oct;19(10):1704-1711. doi: 10.1016/j.hrthm.2022.05.037. Epub 2022 Jun 7.

引用本文的文献

1
[Practical guidance for the implantation of non-transvenous ICD systems].[非经静脉植入式心律转复除颤器系统植入的实用指南]
Herzschrittmacherther Elektrophysiol. 2024 Sep;35(3):226-233. doi: 10.1007/s00399-024-01042-w. Epub 2024 Aug 21.
2
S-ICD Implantation "Tips and Tricks".皮下植入式心律转复除颤器(S-ICD)植入术“技巧与窍门”
Rev Cardiovasc Med. 2023 Jul 10;24(7):195. doi: 10.31083/j.rcm2407195. eCollection 2023 Jul.
3
Management of sensing issues with a subcutaneous implantable cardioverter-defibrillator in a patient with Brugada syndrome: A case report.

本文引用的文献

1
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool.根据一种新型自动筛查工具评估皮下植入式心律转复除颤器的适用性以及与标准手动心电图形态学工具的一致性。
J Interv Card Electrophysiol. 2018 Jun;52(1):61-67. doi: 10.1007/s10840-018-0326-2. Epub 2018 Mar 3.
2
Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.运动负荷试验显示,布加综合征患者不适合植入皮下植入式心律转复除颤器。
J Cardiovasc Electrophysiol. 2017 Dec;28(12):1454-1459. doi: 10.1111/jce.13315. Epub 2017 Sep 1.
3
布加综合征患者皮下植入式心律转复除颤器感知问题的管理:一例报告
HeartRhythm Case Rep. 2023 Sep 16;9(12):878-882. doi: 10.1016/j.hrcr.2023.09.009. eCollection 2023 Dec.
4
Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator.比较接受皮下植入式心脏除颤器患者的术前心电图筛查和基于设备的向量分析。
Medicina (Kaunas). 2023 Dec 16;59(12):2186. doi: 10.3390/medicina59122186.
5
Real-world evidence for the use of subcutaneous implantable cardioverter-defibrillators in China: A single-center experience.中国皮下植入式心律转复除颤器应用的真实世界证据:单中心经验。
Herz. 2023 Dec;48(6):462-469. doi: 10.1007/s00059-023-05192-4. Epub 2023 Aug 4.
6
A case of frequent and inappropriate shock with a subcutaneous implantable cardioverter-defibrillator triggered by newly developed complete right bundle branch block.一例因新出现的完全性右束支传导阻滞引发皮下植入式心律转复除颤器频繁且不适当电击的病例。
HeartRhythm Case Rep. 2022 Jun 6;8(9):606-609. doi: 10.1016/j.hrcr.2022.05.025. eCollection 2022 Sep.
7
A real-world experience of subcutaneous and transvenous implantable cardiac defibrillators-comparison with the PRAETORIAN study.皮下和经静脉植入式心脏除颤器的真实世界经验——与PRAETORIAN研究的比较
J Arrhythm. 2022 Feb 21;38(2):199-212. doi: 10.1002/joa3.12687. eCollection 2022 Apr.
8
Impact of diabetes as a risk factor in patients undergoing subcutaneous implantable cardioverter defibrillator implantation: A single-centre study.糖尿病作为皮下植入式心脏复律除颤器植入患者的风险因素的影响:单中心研究。
Diab Vasc Dis Res. 2020 Mar-Apr;17(2):1479164120911560. doi: 10.1177/1479164120911560.
9
Undetected displacement of a subcutaneous implantable cardioverter-defibrillator lead. importance of performing a chest X-ray during the first weeks post-implant: a case report.皮下植入式心脏复律除颤器导线未被检测到的移位。植入后最初几周进行胸部X线检查的重要性:一例病例报告。
Eur Heart J Case Rep. 2019 Oct 22;3(4):1-5. doi: 10.1093/ehjcr/ytz189. eCollection 2019 Dec.
10
[Appropriate procedure for pacemaker and ICD malfunction].[起搏器和植入式心律转复除颤器故障的恰当处理程序]
Herzschrittmacherther Elektrophysiol. 2020 Mar;31(1):64-72. doi: 10.1007/s00399-020-00669-9. Epub 2020 Feb 7.
Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
皮下植入式心脏复律除颤器注册研究的植入和中期结果:EFFORTLESS 研究。
J Am Coll Cardiol. 2017 Aug 15;70(7):830-841. doi: 10.1016/j.jacc.2017.06.040.
4
Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator.运动心电图在植入皮下植入式心脏除颤器后筛查 T 波过感知中的作用。
Heart Rhythm. 2017 Oct;14(10):1436-1439. doi: 10.1016/j.hrthm.2017.06.022. Epub 2017 Jun 15.
5
The Utility of Exercise Testing in Risk Stratification of Asymptomatic Patients With Type 1 Brugada Pattern.运动试验在1型Brugada波无症状患者危险分层中的应用
J Cardiovasc Electrophysiol. 2017 Jun;28(6):677-683. doi: 10.1111/jce.13205. Epub 2017 Apr 20.
6
Complete right bundle branch block and QRS-T discordance can be the initial clue to detect S-ICD ineligibility.
J Cardiol. 2017 Jul;70(1):23-28. doi: 10.1016/j.jjcc.2016.11.014. Epub 2016 Dec 26.
7
Diaphragmatic Myopotential Oversensing Caused by Change in Implantable Cardioverter Defibrillator Sensing Bandpass Filter.植入式心脏复律除颤器感知带通滤波器变化导致的膈肌肌电位过度感知
Pacing Clin Electrophysiol. 2016 Jul;39(7):774-778. doi: 10.1111/pace.12837. Epub 2016 Mar 31.
8
Prognostic significance of fever-induced Brugada syndrome.发热诱发的Brugada综合征的预后意义。
Heart Rhythm. 2016 Jul;13(7):1515-20. doi: 10.1016/j.hrthm.2016.03.044. Epub 2016 Mar 23.
9
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.皮下植入式心律转复除颤器(ICD)的不适当电击:发生率、预测因素及处理
Int J Cardiol. 2015 Sep 15;195:126-33. doi: 10.1016/j.ijcard.2015.05.135. Epub 2015 May 22.
10
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.全球完全皮下植入式除颤器的经验:来自EFFORTLESS S-ICD注册研究的早期结果。
Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.